Tag - medicine-4

 
 

MEDICINE 4

Japan Times
WORLD / Science & Health
Mar 19, 2021
EU's drug regulator backs 'safe and effective' AstraZeneca vaccine
The news comes following an investigation into reports of blood clots that prompted more than a dozen nations to suspend its use.
Japan Times
WORLD / Science & Health
Mar 16, 2021
Booster vaccines are the future in battle with COVID-19, genome expert says
The measure may be necessary because the novel coronavirus mutates around once every two weeks, requiring tweaks to vaccines.
Japan Times
COMMENTARY / World
Mar 16, 2021
Virus keeps refusing to follow anyone’s partisan script
Among the world's rich countries, the U.S. has a middling COVID-19 death rate: better than the U.K. or Italy, worse than France or Sweden.
Japan Times
WORLD
Mar 15, 2021
AstraZeneca vaccine fears grow as regulators try to ease clot concerns
The drugmaker says more than 17 million doses have been administered in Europe and the U.K., with no evidence that the shot increased the risk of blood clots.
Japan Times
WORLD / FOCUS
Mar 14, 2021
As vaccine nationalism deepens, governments pay to bring production home
Governments across the globe are rushing to access fragmented vaccine production after manufacturing setbacks deprived European Union members of drugs made on their own soil this year.
Japan Times
WORLD
Mar 11, 2021
Denmark suspends AstraZeneca COVID-19 shots for two weeks after blood clot reports
'Both we and the Danish Medicines Agency have to respond to reports of possible serious side-effects, both from Denmark and other European countries,' an official said.
Japan Times
COMMENTARY / World
Mar 11, 2021
Russia has been the Sputnik vaccine’s worst enemy
Now that a peer-reviewed article in The Lancet has established Sputnik as safe and effective, the initial failure of many countries to believe in it looks like a missed opportunity.
Japan Times
JAPAN
Mar 9, 2021
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
Japan Times
JAPAN
Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan Times
WORLD / Science & Health
Mar 4, 2021
The vaccine revolution is coming inside tiny bubbles of fat
If messenger-RNA vaccines are the breakout medicine of the pandemic, then the tiny lipid spheres that bring them into people's cells are the unsung heroes.
Japan Times
JAPAN / Science & Health
Mar 3, 2021
This patch developed in Japan could let you vaccinate yourself
The 'biobattery-powered microneedle patch' allows a vaccine to be absorbed faster than with the medical patches currently available commercially.
Japan Times
WORLD
Mar 3, 2021
Biden expects enough vaccine supplies for all American adults by end of May
U.S. President Joe Biden announced Tuesday that there would be enough doses of the coronavirus vaccine available for the entire adult population in the United States by the end of May, although he said it would take longer to actually inoculate everyone, and he urged people to remain vigilant by wearing...
Japan Times
WORLD
Feb 28, 2021
U.S. authorizes Johnson & Johnson's COVID-19 vaccine
J&J's vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier.
Japan Times
ASIA PACIFIC
Feb 25, 2021
Cautious Asian nations start deploying vaccine now proven elsewhere
With the virus mostly contained throughout much of Asia, governments have had the luxury to wait and see how safely and effectively the vaccines can blunt disease.
Japan Times
WORLD
Feb 25, 2021
Pfizer-BioNTech shot could help end pandemic, Israel study shows
It was the largest study yet to quantify the impact of the vaccine outside the rigorous confines of a randomized, blinded clinical trial aimed at measuring effectiveness for regulators.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?